Pfizer’s Paxlovid reduces Covid risk in seniors regardless of vaccine status ...Middle East

Daily Sun - News
Pfizer’s Paxlovid reduces Covid risk in seniors regardless of vaccine status
JERUSALEM: Pfizer Inc’s antiviral treatment Paxlovid reduces Covid-19 hospitalization and death rates in vaccinated and unvaccinated patients 65 years and older, according to a new study in Israel conducted during the rise of the Omicron variant of the coronavirus.The treatment, however, was not found to prevent severe illness among younger adults, according to research from Clalit Health Services, Israel’s largest healthcare provider.Use of Pfizer’s pills, authorized to treat newly infected, at-risk people in order to prevent severe illness, has soared in the United States along with a spike infections. Biden administration officials have pushed for wide use of Paxlovid, which the governmen

Hence then, the article about pfizer s paxlovid reduces covid risk in seniors regardless of vaccine status was published today ( ) and is available on Daily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer’s Paxlovid reduces Covid risk in seniors regardless of vaccine status )

Apple Storegoogle play

Last updated :

Also on site :